Allogene Therapeutics (ALLO)
Nasdaq • ALLO • US0197701065
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 23, 2026, ORTEX estimated 19.1% of free float sold short, 9.2 days to cover, cost to borrow 0.54%. Sign up for live short interest data.
Market Cap
367m USD | # 6494 in US
Volume
6.76m shares | 11.05m USD
Shares Outstanding
346.47m
Free Float Shares
81.63% | 282.83m
